Laura Kovanda

4.0k citations
57 papers · 3.0k · 2 hit papers · h-index 27

Impact in

    • Antifungal resistance and susceptibility
    • Fungal Infections and Studies
    • Nail Diseases and Treatments
    • Pneumocystis jirovecii pneumonia detection and treatment

Papers in

    • Antifungal resistance and susceptibility 49
    • Fungal Infections and Studies 28
    • Pneumocystis jirovecii pneumonia detection and treatment 8
    • Pneumonia and Respiratory Infections 3

Laura Kovanda

56 papers receiving 2.8k citations

Laura Kovanda's Hit Papers

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation 2017 · 322 citations
3220+6+12Years since publication100200300400500

Peers

Laura Kovanda
Comparison fields: 5 of 81
  • Infectious Diseases 2.5k
  • Epidemiology 1.8k
  • Applied Microbiology and Biotechnology 76
  • Small Animals 240
  • Pharmacology 349
Replace S. Tendolkar with:
S. Tendolkar United States
Н Н Климко Russia
Robert Lupinacci United States
Estrella Martín‐Mazuelos Spain
V. Krčméry Slovakia
Ömrüm Uzun Türkiye
Juergen Prattes Austria
R.A. Barnes United Kingdom
C Kibbler United Kingdom
P. Martino Italy
Laura Kovanda relative to S. Tendolkar United States S. Tendolkar's profile →
Citations per field
00.5×
S. Tendolkar · 1×
Citations per year

Countries citing papers authored by Laura Kovanda

Since Specialization
Citations

This map shows the geographic impact of Laura Kovanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Kovanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Kovanda more than expected).

Fields of papers citing papers by Laura Kovanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Kovanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Kovanda. The network helps show where Laura Kovanda may publish in the future.

Co-authors

The 25 scholars most cited alongside Laura Kovanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laura Kovanda Line = papers co-authored together Laura Kovanda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
Hit paper breakdown →
2007511
2
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation
Hit paper breakdown →
2017322
3 2010178
4 2016158
5 2006132
6 2018128
7 2009117
8 2018112
9 2016109
10 200996
11 201193
12 201790
13 200886
14 201461
15 201657
16 200956
17 202250
18 201847
19 201738
20 201438

About Laura Kovanda

Laura Kovanda is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Small Animals and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (49 papers), Fungal Infections and Studies (28 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Cystic Fibrosis Research Advances (5 papers), Helminth infection and control (5 papers), Infectious Diseases and Mycology (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), Epidemiology (1.8k citations), Applied Microbiology and Biotechnology (76 citations), Small Animals (240 citations) and Pharmacology (349 citations). Laura Kovanda has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Donald N. Buell, William Hope, Amit Desai, Chunzhang Wu, Luis Ostrosky‐Zeichner, Thomas J. Walsh, Márcio Nucci, Robert F. Betts, José A. Vázquez and David R. Andes. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases, The Pediatric Infectious Disease Journal and Medical Mycology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact